Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats

Hypertension Research

Volumn 32, Issue 9, 2009, Pages 786-790

  Shimizu, Hideo ^a   Nakagami, Hironori ^a   Osako, Mariana Kiomy ^a   Nakagami, Futoshi ^a   Kunugiza, Yasuo ^a   Tomita, Tetsuya ^a   Yoshikawa, Hideki ^a   Rakugi, Hiromi ^a   Ogihara, Toshio ^b   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOTENSIN II; BRADYKININ; DEOXYPYRIDINOLINE; IMIDAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CELL ACTIVATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HYPERTENSION; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; OVARIECTOMY; PHARMACOLOGICAL BLOCKING; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; TIBIA; URINE LEVEL;

ABSORPTIOMETRY, PHOTON; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; ENZYME INHIBITORS; FEMALE; HEART RATE; IMIDAZOLIDINES; ISOENZYMES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, INBRED SHR; RATS, WISTAR; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM;

EID: 70249118146     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.99     Document Type: Article

References (25)

1. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: A prospective study. Study of Osteoporotic Fractures Research Group. Lancet 1999; 354: 971-975.
2. Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens 2001; 14: 704-707.
3. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 2004; 15 389-395.
4. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 1997; 28: 1730-1732.
5. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S. Enhanced parathyroid function in essential hypertension: A homeostatic response to a urinary calcium leak. Hypertension 1980; 2: 162-168.
6. Hvarfner A, Bergstrom R, Morlin C, Wide L, Ljunghall S. Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. J Hypertens 1987; 5: 451-456.
7. Imaoka M, Morimoto S, Kitano S, Fukuo F, Ogihara T. Calcium metabolism in elderly hypertensive patients: Possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol 1991; 18: 631-641.
8. Young EW, McCarron DA, Morris CD. Calcium regulating hormones in essential hypertension. Importance of gender. Am J Hypertens 1990; 3: 161S-166S.
9. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med 1983; 309 888-891.
10. Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MA, McNeil AR, Gamble GD. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: A randomized controlled trial. Am J Med 2000; 109: 362-370.
11. Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003; 139: 476-482.
12. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA 2004; 292: 1326-1332.
13. Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 2006; 38: 584-588.
14. Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: A nationwide case-control study. J Hypertens 2006; 24: 581-589.
15. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 2008; 22: 2465-2475.
16. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 1997; 99: 278-287.
17. Shimizu H, Nakagami H, Tsukamoto I, Morita S, Kunugiza Y, Tomita T, Yoshikawa H, Kaneda Y, Ogihara T, Morishita R. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Ther 2006; 13: 933-941.
18. Venken K, Boonen S, Van Herck E, Vandenput L, Kumar N, Sitruk-Ware R, Sundaram K, Bouillon R, Vanderschueren D. Bone and muscle protective potential of the prostatesparing synthetic androgen 7alpha-methyl-19-nortestosterone: Evidence from the aged orchidectomized male rat model. Bone 2005; 36: 663-670.
19. Perez-Castrillon JL, Silva J, Justo I, Sanz A, Martin-Luquero M, Igea R, Escudero P, Pueyo C, Diaz C, Hernandez G, Dueñas A. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: Relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens 2003; 16: 453-459.
20. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K. Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 2009; 24: 241-250.
21. Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 1992; 75: 988-992.
22. Broulik PD, Tesar V, Zima T, Jirsa M. Impact of antihypertensive therapy on the skeleton: Effects of enalapril and AT1 receptor antagonist losartan in female rats. Physiol Res 2001; 50: 353-358.
23. Takeda-Matsubara Y, Nakagami H, Iwai M, Cui TX, Shiuchi T, Akishita M, Nahmias C, Ito M, Horiuchi M. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 2002; 39: 41-45.
24. Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 2005; 45: 545-551.
25. Garcia MP, Gimenez J, Serna M, Salom MG, Bonacasa B, Carbonell LF, Quesada T, Hernandez I. Effect of estrogen and angiotensin-converting enzyme inhibitor on vascular remodeling in ovariectomized spontaneously hypertensive rats. Menopause 2006; 13: 397-403.